Vicki L. Goodman, Chief Medical Officer of Mural Oncology plc ($MURA), made one open market sale of common shares in the last year, totaling $10,475. Her most recent transaction occurred on November 10, 2025. Among 11,678 insiders with sales, her activity ranks 11,265th by amount, well below the $8.6 million average across 6.4 transactions. She reported no open market purchases.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | D | Ordinary Shares | 84727 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.49% |
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | D | Stock Option (right to buy) | 65000 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.37% |
| Dec. 5, 2025 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | D | Stock Option (right to buy) | 135604 | $0.00 | 0.0000 | 17,344,486 | 100.00% | 0.78% |
| Nov. 10, 2025 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | S | Ordinary Shares | 5036 | $2.08 | 84,727.0000 | 17,344,486 | 5.61% | 0.03% |
| March 3, 2025 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | A | Ordinary Shares | 35000 | $0.00 | 89,763.0000 | 17,228,291 | 63.91% | 0.20% |
| March 3, 2025 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | A | Stock Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 17,228,291 | 9999.99% | 0.38% |
| Feb. 24, 2025 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | S | Ordinary Shares | 13186 | $3.89 | 54,763.0000 | 0 | 19.41% | 0.00% |
| Nov. 7, 2024 | Mural Oncology plc | $MURA | Goodman Vicki L | Chief Medical Officer | S | Ordinary Shares | 5069 | $3.33 | 67,949.0000 | 0 | 6.94% | 0.00% |
| April 3, 2023 | EXELIXIS, INC. | $EXEL | Goodman Vicki L | EVP, Prod Dev & Med Aff &CMO | A | Common Stock | 82566 | $0.00 | 307,654.0000 | 324,556,000 | 36.68% | 0.03% |
| Feb. 15, 2023 | EXELIXIS, INC. | $EXEL | Goodman Vicki L | EVP, Prod Dev & Med Aff &CMO | F | Common Stock | 17299 | $18.08 | 225,088.0000 | 324,556,000 | 7.14% | 0.01% |